1.Pancreatic Uncinate Process Adenocarcinoma.
Journal of the Korean Medical Association 2000;43(3):270-276
No abstract available.
Adenocarcinoma*
2.An Immunohistochemical Study of CA 125, CA 19-9, and CA 15-3 in Ovarian Epithelial Tumors.
Hye Rim PARK ; Hye Kyung AHN ; Young Euy PARK ; Joo Hyun NAM
Korean Journal of Pathology 1993;27(2):134-142
To evaluate the relationship between the expression of CA 125, CA 19-9, and CA 15-3 and ovarian epithelial tumors, immunohistochemical stainings were performed and analyzed to the types of tumor, and the degree o malignancy and differentiation in the total 42 cases. The results were summarized as follows: 1) The expression of CA 19-9 and CA 15-3 was demonstrated in most cases of benign, borderline and malignant mucinous tumors. All types tumors were negative for CA 125. 2) All types of serous tumors including benign, borderline and malignant revealed strong positive reaction for CA 125 and CA 15-3 in contrast to some weak positivity for CA 19-9. Expression of CA 125 was significantly increased in high grade serous adenocarcinomas compared with low of grade. 3) Endometrioid carcinomas revealed strong positive reaction for CA 15-3 in contrast to some positivity for CA 125 and CA 19-9. One case of Brenner tumor expressed CA 19-9 and CA 15-3 without expression of CA 125. 4) Serum CA 125 levels were elevated in 80% and CA 15-3 levels in 100% of ovarian epithelial malignancy. The correlation between serum levels and staining intensities was moderate.
Adenocarcinoma
3.A clinical study of gastric adenocarcinoma and experience in the use of EEA stapler.
Journal of the Korean Surgical Society 1993;45(2):209-217
No abstract available.
Adenocarcinoma*
4.The prognostic significance of expression of proliferating cell nuclear antigen(PCNA) in prostatic adenocarcinoma.
Joon CHUN ; Je Jong KIM ; Han Kyum KIM ; In Sun KIM ; Sung Kun KOH
Journal of the Korean Cancer Association 1993;25(6):947-955
No abstract available.
Adenocarcinoma*
5.A Comparative Study between Localization of IgA and Secretory Component in Gastric Disease.
Joon Hyuk CHOI ; Won Hee CHOI ; Tae Sook LEE
Korean Journal of Pathology 1991;25(6):509-519
The purpose of this study is to evaluate the change of mucosal immunity in gastric diseases. A quantative analysis of IgA and secretory component(SC) in gastric diseases by immunohistochemical method was performed in 110 specimens. The results are as follows: 1) In normal gastric mucosa, all of 10 cases revealed a negative reaction to antihuman SC but 4 cases were positive for IgA. 2) In chronic superficial gastritis and chronic atrophic gastritis with intestinal metaplasia, the metaplastic cells except for the goblet cells were positive for both IgA and SC. 3) The dysplastic cells were also positive for both IgA and SC, and the regenerating cells in ulcer as well. 4) All of the well differentiated or moderately well differentiated adenocarcinomas showed positive reactions to antihuman IgA and antihuman SC, and the intensity appeared to be stronger in the former. However, among 10 cases of poorly differentiated adenocarcinoma SC was not demonstrated in 5 cases, and no IgA was present in one case. In 10 cases of signet ring cell carcinoma, 6 cases revealed a negative reaction to antihuman IgA and 6 cases to antihuman SC. The above results suggest that the secretory immunity is not essential in normal gastric mucosa. The intestinal metaplasia in chronic gastritis is considered as an adaptive response to chronic inflammation. The degree of differentiation in adenocarcinoma may be related to the mucosal immunity.
Adenocarcinoma
6.Primary appendiceal adenocarcinoma.
Jae Sub PARK ; Sung Hoon NOH ; Jin Sik MIN
Journal of the Korean Surgical Society 1991;41(4):496-502
No abstract available.
Adenocarcinoma*
7.The Outcomes of 17,744 Cervicovaginal Smears in Ihha University Hospital.
Eun Seop SONG ; Sang Hoon HAN ; Jee Hyun PARK ; Kwoan Young OH ; Young Koo LIM ; Moon Whan IM ; Byoung Ick LEE ; Jee Young HAN ; Jong Hwa KIM
Korean Journal of Obstetrics and Gynecology 2000;43(3):363-367
OBJECTIVE: Our purpose was to investigate the distribution of the result of 17,744 cervicovaginal smears and their pathologic results in Inha University Hospital to make a reference data. METHODS: During 28 months, May 1996 to August 1998, we performed 17,774 cervicovaginal smears and arranged them by the Bethesda system and compared them with their pathologic results. RESULTS: Among 17,744 smears, there were 93.2% of benign results, 2.9% of ASCUS, 0.9% of LSIL, 1.4% of HSIL, and 0.8% of SCC. The ASCUS/SIL ratio was 1.28. Among ASCUS, the high grade histologic outcome was composed 4.0%. Among LSIL, there were 15.7%, and HSIL 48.0%, SCC 56.1%, AGUS 9.3%, and Adenocarcinoma, the results was 69.2%. CONCLUSION: Among 17,744 smears, there were 93.2% of benign results, 2.9% of ASCUS, 0.9% of LSIL, 1.4% of HSIL, and 0.8% of SCC. The ASCUS/SIL ratio was 1.28. These results were very similar to other data and we would like to add our data to them as a reference. And the worse the smear results were, the worse the pathologic results were.
Adenocarcinoma
8.Mucinous Adenocarcinoma of Anal Ducts.
Young Ha OH ; Wan Seop KIM ; Eun Kyung HONG ; Moon Hyang PARK ; Jung Dal LEE
Korean Journal of Pathology 1996;30(9):843-850
Anal duct carcinoma is a rare tumor, and accounts for less than 5 percent of all anal cancers, which typically present a long-standing perianal fistulas. Some authors suggest that the fistulous tracts are congenital duplications of the lower end of the hind gut lined by rectal mucosa which is prone to malignant change to mucinous adenocarcinoma. It is usually a well differentiated mucinous (colloid) adenocarcinoma. The prognosis after wide excision of the rectum is relatively good. Since 1985, we have had three cases of anal duct carcinoma with well differentiated mucinous adenocarcinoma involving the posterior wall of the anus. Two patients had a long history of perianal fistula with mucinous discharge. There was no spread to the regional lymph node except one patient who had regional lymph node metastasis, and post-operative chemotherapy and radiation therapy were then given. All patients have no evidence of any recurrent problem at 16 months to 3 years following the surgical treatment. Because of their rarity and the failure of recognition at an early stage, we are presenting three cases to emphasize the characteristic features of this insidious, slow-growing carcinoma.
Adenocarcinoma
9.Goblet Cell Carcinoid of the Appendix: A case report.
Joo Heon KIM ; Ho LEE ; So Young OH ; Myoung Jae KANG ; Ho Yeul CHOI ; Dong Geun LEE
Korean Journal of Pathology 1996;30(9):839-842
Carcinoid tumors of the appendix are common incidental findings, but appendiceal tumors with histologic features of both carcinoids and adenocarcinomas are rare, and their biologic behavior and histogenesis are still unclear. We report a case of goblet cell carcinoid of the appendix in a 54-year-old male, who exhibited pain in the right lower abdomen. Microscopically, the tumor contained smooth-bordered, widely separated nests composed of tumor cells with abundant mucin. The principal tumor cell type had a close resemblance to the normal goblet cell. Histochemically, the tumor cells revealed positive reaction for PAS and alcian blue stain. Immunohistochemically, the tumor showed strong reactivity for carcinoembryonic antigen, chromogranin and, neuron specific enolase but none for cytokeratin and epithelial membrane antigen.
Adenocarcinoma
10.Carcinoma Erysipelatoides Originating from Gastic Adenocarcinoma.
Hee Kyeong LIM ; Min Kyung SHIN ; Nack In KIM
Korean Journal of Dermatology 2013;51(9):747-748
No abstract available.
Adenocarcinoma